156 related articles for article (PubMed ID: 28634489)
21. [Three cases of resected primary mediastinal yolk sac tumor following six courses of bleomycin, etoposide and cisplatin (BEP) combination chemotherapy].
Fujita A; Ohbuchi Y; Morikawa T; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1981-4. PubMed ID: 8978807
[TBL] [Abstract][Full Text] [Related]
22. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
[TBL] [Abstract][Full Text] [Related]
23. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
[TBL] [Abstract][Full Text] [Related]
25. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
Farhat F; Culine S; Théodore C; Békradda M; Terrier-Lacombe MJ; Droz JP
Cancer; 1996 Mar; 77(6):1193-7. PubMed ID: 8635143
[TBL] [Abstract][Full Text] [Related]
27. Relapsed and refractory yolk sac tumor of the peritoneum (mesentery): A case report and literature review.
Zhou X; Zhao L; Feng X; Pan Z; Bin Y; Zhang S; Li M; Guo M; Hou H; Li Q
Front Oncol; 2022; 12():928234. PubMed ID: 36016622
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
[TBL] [Abstract][Full Text] [Related]
29. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
Loehrer PJ; Gonin R; Nichols CR; Weathers T; Einhorn LH
J Clin Oncol; 1998 Jul; 16(7):2500-4. PubMed ID: 9667270
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
[TBL] [Abstract][Full Text] [Related]
31. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
32. [Intra-arterial infusion chemotherapy for liver metastases of testicular tumors: report of two cases].
Tanase K; Tawada M; Moriyama N; Muranaka K
Hinyokika Kiyo; 2000 Nov; 46(11):823-7. PubMed ID: 11193306
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
Broun ER; Nichols CR; Kneebone P; Williams SD; Loehrer PJ; Einhorn LH; Tricot GJ
Ann Intern Med; 1992 Jul; 117(2):124-8. PubMed ID: 1318648
[TBL] [Abstract][Full Text] [Related]
35. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
37. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
38. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
40. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
Uekado Y; Matsumoto M; Inagaki T; Shintani Y
Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]